RE:RE:Sounds like we have a treatment for Cancer
its actually approved for 3 cancers and doing phase 3 for bile duct cancer The newly approved laser, which is designed for use with Photofrin to treat esophageal cancer, Barrett's Esophagus and non-small cell lung cancer, has been re-engineered with technological advancements in laser design. These advancements include new controls and peripheral systems while maintaining the same specifications with minimal changes to the treatment procedures. The Company is also evaluating Photofrin as a rare disease product candidate through a Phase 3 clinical trial. The ongoing Phase 3 trial is evaluating the product's safety and efficacy as a potential treatment for cholangiocarcinoma, or bile duct cancer, which is a rare disease affecting approximately 2,000-3,000 patients annually in the United States.